Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Craig Y Okada

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|October 23, 2002
Tumor cell lysate-pulsed dendritic cells are more effective than TCR Id protein vaccines for active immunotherapy of T cell lymphomaErin Gatza, Craig Y Okada
Cancer Immunology, Immunotherapy : CII|July 19, 2005
Adjuvant IL-15 does not enhance the efficacy of tumor cell lysate-pulsed dendritic cell vaccines for active immunotherapy of T cell lymphomaErin Gatza, Craig Y Okada
Journal of Immunology (Baltimore, Md. : 1950)|January 7, 2004
TCR vaccines against a murine T cell lymphoma: a primary role for antibodies of the IgG2c class in tumor protectionStacie L Lambert, Craig Y Okada, Ronald Levy
Clinics in Colon and Rectal Surgery|September 7, 2018
Colorectal Lymphoma: A ReviewNathan D Gay, Andy Chen, Craig Y Okada
Journal of Neuro-Ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society|June 5, 2004
Galloping ophthalmoplegia and numb chin in Burkitt lymphomaJuan J Chan Lau, Craig Y Okada, Jonathan D Trobe
Therapeutic Advances in Hematology|May 6, 2017
Targeting the programmed cell death 1 pathway in Hodgkin lymphoma: the place of nivolumabNathan D Gay, Craig Y Okada, Andy I Chen, et al.
Dermatology Online Journal|November 19, 2019
Primary cutaneous Epstein-Barr virus-positive diffuse large B-cell lymphoma (DLBCL) in a patient taking fingolimodAbby Wills, Guang Fan, Edward Kim, et al.
Leukemia & Lymphoma|December 5, 2017
Outcomes of DA-EPOCH-R induction plus autologous transplant consolidation for double hit lymphomaAndy I Chen, Jessica T Leonard, Craig Y Okada, et al.
Molecular Cancer Therapeutics|June 28, 2019
Cyclin-Dependent Kinase-9 Is a Therapeutic Target in MYC-Expressing Diffuse Large B-Cell LymphomaTaylor Hashiguchi, Nur Bruss, Scott Best, et al.
Blood|February 28, 2002
Idiotype-pulsed dendritic cell vaccination for B-cell lymphoma: clinical and immune responses in 35 patientsJohn M Timmerman, Debra K Czerwinski, Thomas A Davis, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Journal of Immunology (Baltimore, Md. : 1950)|October 23, 2002
Tumor cell lysate-pulsed dendritic cells are more effective than TCR Id protein vaccines for active immunotherapy of T cell lymphomaErin Gatza, Craig Y Okada
Cancer Immunology, Immunotherapy : CII|July 19, 2005
Adjuvant IL-15 does not enhance the efficacy of tumor cell lysate-pulsed dendritic cell vaccines for active immunotherapy of T cell lymphomaErin Gatza, Craig Y Okada
Journal of Immunology (Baltimore, Md. : 1950)|January 7, 2004
TCR vaccines against a murine T cell lymphoma: a primary role for antibodies of the IgG2c class in tumor protectionStacie L Lambert, Craig Y Okada, Ronald Levy
Clinics in Colon and Rectal Surgery|September 7, 2018
Colorectal Lymphoma: A ReviewNathan D Gay, Andy Chen, Craig Y Okada
Journal of Neuro-Ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society|June 5, 2004
Galloping ophthalmoplegia and numb chin in Burkitt lymphomaJuan J Chan Lau, Craig Y Okada, Jonathan D Trobe
Therapeutic Advances in Hematology|May 6, 2017
Targeting the programmed cell death 1 pathway in Hodgkin lymphoma: the place of nivolumabNathan D Gay, Craig Y Okada, Andy I Chen, et al.
Dermatology Online Journal|November 19, 2019
Primary cutaneous Epstein-Barr virus-positive diffuse large B-cell lymphoma (DLBCL) in a patient taking fingolimodAbby Wills, Guang Fan, Edward Kim, et al.
Leukemia & Lymphoma|December 5, 2017
Outcomes of DA-EPOCH-R induction plus autologous transplant consolidation for double hit lymphomaAndy I Chen, Jessica T Leonard, Craig Y Okada, et al.
Molecular Cancer Therapeutics|June 28, 2019
Cyclin-Dependent Kinase-9 Is a Therapeutic Target in MYC-Expressing Diffuse Large B-Cell LymphomaTaylor Hashiguchi, Nur Bruss, Scott Best, et al.
Blood|February 28, 2002
Idiotype-pulsed dendritic cell vaccination for B-cell lymphoma: clinical and immune responses in 35 patientsJohn M Timmerman, Debra K Czerwinski, Thomas A Davis, et al.
Pageof 2